BIO-RAD LABORATORIES, INC. — Director's Dealing 2021

Sep 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-09-03

Reporting Person: ERNST TIMOTHY S (EVP, General Counsel & Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-03	Bio-Rad A Common Stock	M	464	$.00	Acquired	1619.0531	Direct
2021-09-03	Bio-Rad A Common Stock	F	222	$819.70	Disposed	1397.0531	Direct
2021-09-04	Bio-Rad A Common Stock	M	500	$.00	Acquired	1897.0531	Direct
2021-09-04	Bio-Rad A Common Stock	F	248	$819.70	Disposed	1649.0531	Direct
2021-09-05	Bio-Rad A Common Stock	M	500	$.00	Acquired	2149.0531	Direct
2021-09-05	Bio-Rad A Common Stock	F	248	$819.70	Disposed	1901.0531	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-03	Restricted Stock Units	$0	M	464	Disposed		Bio-Rad A Common Stock (464)	Direct
2021-09-04	Restricted Stock Units	$0	M	500	Disposed		Bio-Rad A Common Stock (500)	Direct
2021-09-05	Restricted Stock Units	$0	M	500	Disposed		Bio-Rad A Common Stock (500)	Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: On September 3, 2019, the reporting person was granted 2,320 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

F4: On September 4, 2018, the reporting person was granted 2,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

F5: On September 5, 2017, the reporting person was granted 2,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.